Skip to main content

Table 1 Measles cases in the 10 years following the ESEN2 serological study, and mean estimated population immunity (contact-adjusted or not, with fixed R0 and equivocal samples interpreted as positive) based on the study and adjusted for vaccination uptake

From: Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination

  Cases Immunity
Country Total (10 years) Maximum annual Mean annual (per million) Maximum annual (per million) Contact-adjusted Plain
Slovakia 2 2 0.037 0.37 0.96 0.96
Hungary 12 5 0.12 0.5 0.95 0.95
Czech Republic 84 30 0.82 2.9 0.98 0.98
Latvia 16 7 0.72 3.1 0.71 0.82
Sweden 210 62 2.4 7 0.94 0.94
Lithuania 58 35 1.7 10 0.91 0.93
Slovenia 26 22 1.3 11 0.96 0.96
Malta 14 6 3.5 15 0.93 0.95
Luxembourg 10 8 2.3 18 0.95 0.96
UK 6001 1445 10 25 0.92 0.96
Spain 3419 1842 8.6 46 0.95 0.98
Belgium 1066 576 10 56 0.85 0.94
Cyprus 111 90 11 87 0.84 0.93
Ireland 1687 443 40 105 0.88 0.91
Israel 1792 931 30 155 0.94 0.95
Romania 20570 7450 93 337 0.92 0.96
Bulgaria 24416 22004 305 2750 0.82 0.88